Industry

  EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Ladenburg Thalmann 2022 Healthcare Conference on Thursday, September 29 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time). The conference is being held at the Sofitel … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Neurotrophic Keratitis Market (2022-2027) by Route of Administration, Distribution Channel, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Neurotrophic Keratitis Market is estimated to be worth USD 191.1 million in 2022, and is expected to reach USD 439.05 million by … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–$JANX—Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced the appointment of Brenda Van Vreeswyk as Head of Human Resources (HR). Ms. Van Vreeswyk brings … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–AlivaMab Discovery Services (“ADS”), a leader in the discovery of superior antibody-based therapeutics, announced that Larry Green has reassumed the role of Chief Executive Officer, effective immediately. He assumes the role from Justin Mika. Dr. Green, who brings over 30 years’ experience in antibody drug discovery and development, is the founding Chief Executive … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Healthcare Payer Services Market Research Report by Outsourcing Services (BPO, ITO, and KPO), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Healthcare Payer Services Market size was estimated at USD … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Ketamine (CAS 6740-88-1) Global Market Research Report 2022” report has been added to ResearchAndMarkets.com’s offering. This global report is a result of industry experts’ diligent work on researching the world market of Ketamine. The report helps to build up a clear view of the market trends and development, identify major players in the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Media, Sera and Reagent Market Research and Forecast 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global media, sera, and reagents market is growing at a considerable CAGR of 5.8% during the forecast period. Rising R&D towards the market is one of the prime factors affecting and driving the market. Increasing … [Read more…]

FRANKFURT, Germany–(BUSINESS WIRE)–OFB Projektentwicklung has started the first construction phase of the “BioSquare Leipzig” on a partial area of around 11,600 m² of the construction site 6a on the street “Alte Messe.” The symbolic groundbreaking ceremony on September 22, 2022, took place in the presence of Thomas Dienberg (Mayor for Urban Development and Construction of … [Read more…]

LifeWorks survey reveals Canadian organizations are experiencing the impacts of inflation and labour shortages during world-wide uncertainty TORONTO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its 40th annual Salary Projection Survey. The findings revealed much higher Canadian base salaries than initially projected, increasing 4.01 per cent in 2022 and … [Read more…]

Preliminary data set presented at EORTC CLTG annual meeting confirms clinical activity and favorable safety profile of lacutamab in patients with mycosis fungoides who express KIR3DL2 and who were previously treated with at least two lines of systemic therapy MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) … [Read more…]